Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Overview | Management | Board of Directors | Strategic Alliances | Partnering | Contact Us
    About - Management

We are a biopharmaceutical company developing small molecule therapeutics derived from our boron chemistry platform Learn more about Kerydin
Learn more about AN2728


Paul L. Berns
Chief Executive Officer

Graeme Bell
Executive Vice President and Chief Financial Officer

Vince Ippolito
Executive Vice President and Chief Commercial Officer

Lee T. Zane, M.D.
Senior Vice President and Chief Medical Officer

Sanjay Chanda, Ph.D.
Senior Vice President, Drug Development

Kirk R. Maples, Ph.D.
Senior Vice President, Program Management

Jacob J. Plattner, Ph.D.
Senior Vice President, Research

Carmen Rodriguez
Senior Vice President, Regulatory Affairs & Quality Assurance

Ryan T. Sullivan
Senior Vice President and General Counsel

Erik D. Wiberg
Senior Vice President, Strategy & Corporate Development